Prospective evaluation of pathologic response with neoadjuvant chemo-immunotherapy in metaplastic breast cancer

被引:0
|
作者
Abuhadra, Nour
Chen, Yuan
Plitas, George
Razavi, Pedram
Pareja, Fresia
Reis-Filho, Jorge S.
Wen, Hannah Yong
Khan, Atif J.
Traina, Tiffany A.
Downs-Canner, Stephanie
Robson, Mark E.
Norton, Larry
Montagna, Giacomo
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY USA
[3] Mem Sloan Kettering, Breast & Imaging Ctr, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, Middletown, NJ USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
606
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Dramatic response of metaplastic breast cancer to chemo-immunotherapy
    Adams, Sylvia
    [J]. NPJ BREAST CANCER, 2017, 3
  • [2] Dramatic response of metaplastic breast cancer to chemo-immunotherapy
    Sylvia Adams
    [J]. npj Breast Cancer, 3
  • [3] Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer
    Perry, Lauren M.
    Sevilimedu, Varadan
    Polidorio, Natalia
    Abuhadra, Nour
    Morrow, Monica
    Plitas, George
    Downs-Canner, Stephanie
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S102 - S102
  • [4] Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer
    Yam, Clinton
    Abuhadra, Nour
    Sun, Ryan
    Adrada, Beatriz E.
    Ding, Qing-Qing
    White, Jason B.
    Ravenberg, Elizabeth E.
    Clayborn, Alyson R.
    Valero, Vicente
    Tripathy, Debu
    Damodaran, Senthilkumar
    Arun, Banu K.
    Litton, Jennifer K.
    Ueno, Naoto T.
    Murthy, Rashmi K.
    Lim, Bora
    Baez, Luis
    Li, Xiaoxian
    Buzdar, Aman U.
    Hortobagyi, Gabriel N.
    Thompson, Alistair M.
    A. Mittendori, Elizabeth
    Rauch, Gaiane M.
    Candelaria, Rosalind P.
    Huo, Lei
    Moulder, Stacy L.
    Chang, Jeffrey T.
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2878 - 2889
  • [5] Impact of Race on Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy and Chemotherapy Alone for Early-Stage Triple-Negative Breast Cancer
    Polidorio, Natalia
    Perry, Lauren M.
    Sevilimedu, Varadan
    Montagna, Giacomo
    Abuhadra, Nour
    Morrow, Monica
    Downs-Canner, Stephanie
    Plitas, George
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S10 - S10
  • [6] ADJUVANT CHEMO-IMMUNOTHERAPY IN BREAST-CANCER
    JORGENSEN, OG
    GUNDERSEN, S
    [J]. ACTA CHIRURGICA SCANDINAVICA, 1981, : 109 - 109
  • [7] Body mass index and response to neoadjuvant chemo-immunotherapy among women with primary triple negative breast cancer
    Shen, Sherry
    Myers, Sara
    Chen, Yuan
    Downs-Canner, Stephanie
    Abuhadra, Nour
    Traina, Tiffany
    Robson, Mark
    Iyengar, Neil
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [8] A Case of Pathologic Complete Response to Neoadjuvant Chemotherapy and Pembrolizumab in Metaplastic Breast Cancer
    Gul, Anita
    Alberty-Oller, J. Jaime
    Sandhu, Jagbir
    Ayala-Bustamante, Everick
    Adams, Sylvia
    [J]. JCO PRECISION ONCOLOGY, 2023, 7
  • [9] NSCLC: Resection after neoadjuvant Chemo-immunotherapy
    Lorenz, Judith
    [J]. ZENTRALBLATT FUR CHIRURGIE, 2022, 147 (01): : 17 - 17
  • [10] Chemo-immunotherapy and chemo-adoptive immunotherapy of cancer
    Gomez, GG
    Hutchison, RB
    Kruse, CA
    [J]. CANCER TREATMENT REVIEWS, 2001, 27 (06) : 375 - 402